Trusted Resources: Education
Scientific literature and patient education texts
Combined Aortic and Mitral Valve Stenosis in Mucopolysaccharidosis Syndrome Type I-S: A Report of a Rare Case
source: The journal of Tehran Heart Center
year: 2021
authors: Sadeghian H,Sadeghian A,Eslami B,Abbasi SH,Lotfi-Tokaldany M
summary/abstract:Mucopolysaccharidosis (MPS) syndrome is an inherited metabolic disorder. In more than half of the patients with MPS syndrome, heart valve involvement is reported; however, combined aortic and mitral valve stenosis in MPS syndrome type I-S is very rare. We describe a 39-year-old man with severe mitral and aortic valve stenosis due to MPS syndrome type I-S. Transthoracic and transesophageal echocardiography revealed severe thickening and calcification in the aortic and mitral valves with severe left ventricular hypertrophy. The coronary arteries were normal in angiography.
organization: Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.DOI: 10.18502/jthc.v16i1.6598
read more
BookmarkRelated Content
-
Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis in a Patient With Mucopolysaccharidosis Type II (...Mucopolysaccharidosis type II, known as ...
-
Mucopolysaccharide Storage Disease Type I: Hurler, Hurler-Scheie, and Scheie Syndromeshttps://www.youtube.com/watch?v=en9M2P8S...
-
Mucopolysaccharidosis Type I Diagnosed by Aortic and Mitral Valve ReplacementA 32-year-old developmentally delayed ma...
-
Mucopolysacharidosis Type I Presenting as Bipolar Affective Disorder: A Case ReportMucopolysacharidosis type I is a multisy...
-
A Guide to Understanding MPS IMPS I is a mucopolysaccharide disease al...
-
Spectrum of MPS 1 H/S Diseasehttps://www.onempsvoice.com/wp-content/u...
-
EMA Grants Orphan Drug Designation to JR-171 for the Treatment of Mucopolysaccaridosis Type I (MPS I)JCR Pharmaceuticals Co., Ltd. announced ...
Powered by
